Hepatitis C drugs boost Remdesivir's antiviral activity against COVID-19
(University of Texas at Austin) Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the SARS-CoV-2 coronavirus in cell cultures, according to a new study in Cell Reports.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Coronavirus | COVID-19 | Hepatitis | Hepatitis C | International Medicine & Public Health | SARS | Study | Texas University